FDA drug recalls

Formal FDA enforcement reports for prescription and over-the-counter drugs — contamination, wrong potency, mislabeling, and manufacturing failures. 341 recalls in the last 12 months, in plain English.

Recent recalls

Page 7 of 12
  • Inventia chlorthalidone tablets recalled for failed dissolution

    Inventia Healthcare Limited's chlorthalidone 25 mg tablets failed to meet dissolution specifications, meaning the tablets may not break down properly in the body and deliver the full dose. This affects 100-tablet and 1000-tablet bottles distributed nationwide. No injuries have been reported.

    ModerateFDAJun 24, 2026Inventia Healthcare

  • Sandoz Focalin XR recalled for missing expiration date

    Sandoz is recalling one lot of Focalin XR (dexmethylphenidate HCl) 5 mg extended-release capsules because some bottles have incorrect or missing lot numbers and expiration dates on the label. The affected lot (VA0099422) was distributed nationwide. This is a labeling issue only; the medication itself has not been found to be unsafe.

    FDAJun 24, 2026Sandoz

  • Pearson, Quala and more benzocaine gels recalled for incomplete seals

    Keystone Industries is recalling 7 topical anesthetic gels containing 20% benzocaine, sold as Pearson Quality, Quala, DHP, Burkhart, Dental City, PureLife, and safco SensiCaine-Ultra. The recall is due to a container defect: some bottles may have incomplete seals. No injuries have been reported.

    ModerateFDAJun 24, 2026Keystone Industries7 products

  • Par Health USA buprenorphine injection recalled for crystallization

    Par Health USA's buprenorphine HCl injection (0.3 mg/mL) has been found to contain crystallization identified as buprenorphine free base in certain lots. This affects vials distributed nationwide. The FDA has classified this as a Class II recall.

    ModerateFDAJun 24, 2026Paragon 28

  • Ajanta aripiprazole tablets recalled for voriconazole mix-up

    Ajanta Pharma USA Inc. distributed bottles labeled as Aripiprazole 30 mg that actually contained Voriconazole 50 mg, a different medication used to treat fungal infections. This mix-up affected 6,143 bottles (Lot PA00805, expiring 01/31/2029) distributed nationwide. The error was discovered and reported to the FDA.

    SeriousFDAJun 24, 2026Ajanta Pharma

  • IntegraDose Vasopressin syringes recalled for subpotency

    IntegraDose Compounding Services LLC is recalling Vasopressin 2 Units/2 mL syringes because the drug may contain less active ingredient than labeled. This affects two specific lots distributed nationwide. No injuries have been reported.

    ModerateFDAJun 24, 2026IntegraDose

  • Kerr Insta-Char charcoal recalled for not meeting OTC standards

    VistaPharm is recalling four sizes of Kerr Insta-Char activated charcoal with cherry flavor, in aqueous and sorbitol bases. The product did not meet the FDA over-the-counter monograph M023 standard. No injuries have been reported.

    ModerateFDAJun 24, 2026Pain Train Salsa4 products

  • Glenmark Alyacen 7/7/7 tablets recalled for impurity levels

    Glenmark Pharmaceuticals is recalling specific lots of Alyacen 7/7/7 (a birth control pill) because testing found higher-than-allowed impurity levels in the tablets. The affected lots were distributed nationwide. No injuries have been reported.

    ModerateFDAJun 24, 2026Glenmark

  • Sun Pharmaceutical budesonide inhalation suspension recalled for foreign particles

    Sun Pharmaceutical has recalled budesonide inhalation suspension (1mg/2mL single-dose ampules) due to the presence of black or brown specs and particles found in some vials. The affected lot is BAG0074A with an expiration date of January 31, 2027. This is a quality issue that could affect the safety and sterility of the medication.

    ModerateFDAJun 17, 2026Sun Pharmaceutical

  • Ascend minocycline tablets recalled for failed dissolution test

    Ascend Laboratories is recalling Minocycline Hydrochloride Extended-Release Tablets, 115 mg (lot 25141635, expires 4/30/2028) because testing found the tablets did not dissolve properly as required. This affects 360 bottles distributed nationwide. No injuries have been reported.

    ModerateFDAJun 17, 2026Ascend Laboratories

  • Gas-X Extra Strength SoftGels recalled for coolant contamination

    Gas-X Extra Strength softgels were contaminated with a diluted propylene glycol-based coolant during packaging due to a machine leak. The contamination affected specific lot numbers distributed nationwide. No injuries have been reported.

    SeriousFDAJun 17, 2026Haleon

  • Golden State Medical Supply niacin tablets recalled for dissolution failure

    Golden State Medical Supply is recalling specific lots of niacin extended-release tablets (1,000 mg) because they failed to dissolve properly during stability testing. The tablets did not meet dissolution specifications at the 24-hour mark, which means they may not release the medication as intended in the body.

    ModerateFDAJun 17, 2026Golden State Medical Supply

  • Zep Alcohol Sanitizer Spray recalled for microbial contamination

    Zep Inc. is recalling Alcohol Sanitizer Spray (Ethanol 70%, 55-gallon drums) due to microbial contamination. The affected batch (E2612116, expiration April 2029) was distributed nationwide. A total of 5 drums are involved.

    ModerateFDAJun 17, 2026Zep

  • Amneal primidone tablets recalled for possible cross-contamination

    Amneal Pharmaceuticals is recalling Primidone 50 mg tablets (NDC 53746-544-01, lot AM251676) due to potential cross-contamination with Acemetacin during manufacturing at the API supplier. The contamination could affect the safety or effectiveness of the medication.

    ModerateFDAJun 17, 2026Amneal Pharmaceuticals

  • Breckenridge duloxetine capsules recalled for nitrosamine impurity

    Breckenridge is recalling two sizes of duloxetine delayed-release capsules, 30 mg and 60 mg, made by Towa Pharmaceutical Europe in Spain. The recall covers about 374,400 bottles distributed nationwide. The capsules contain an impurity called N-nitroso-duloxetine at a level above the FDA's recommended interim limit. No injuries have been reported.

    ModerateFDAJun 17, 2026Breckenridge2 products

  • Fresenius Kabi epinephrine injection recalled for impurity concerns

    Fresenius Kabi USA is recalling specific batches of epinephrine injection due to failed impurity and degradation specifications. The affected vials may not meet required purity standards. No injuries have been reported.

    ModerateFDAJun 17, 2026Fresenius Kabi

  • Sun Pharmaceutical doxorubicin injection recalled for glass particles

    Sun Pharmaceutical's doxorubicin hydrochloride liposome injection vials were found to contain glass particles. The affected vials are lot HAG2581B, which expire in May 2027. About 675 vials were distributed nationwide.

    SeriousFDAJun 17, 2026Sun Pharmaceutical

  • Beekeeper's Naturals nasal spray recalled for microbial contamination

    Beekeeper's Naturals Saline Nasal Spray was manufactured without proper sterilization, allowing microbial contamination. The affected product is Lot #5950 with an expiration date of 02/2028. No injuries have been reported so far.

    ModerateFDAJun 17, 2026Beekeeper's Naturals2 products

  • Tums, CAREone and more antacid tablets recalled for metallic particles

    Guardian Drug is recalling 12 calcium carbonate antacid chewable tablet products because small metallic particles were found in the tablets. The products are sold under the Tums (Haleon), CAREone, Discount Drug Mart, HyVee, GoodSense, Equaline and TopCare names. No injuries have been reported.

    ModerateFDAJun 10, 2026Guardian Drug12 products

  • Spectra lidocaine injection recalled for lack of sterility assurance

    Spectra Medical Devices, LLC is recalling Lidocaine HCl Injection USP in 25-count boxes of 5 mL single-dose ampules, made in South Korea, because the product lacks assurance of sterility. The FDA classified this as a Class II recall. No injuries have been reported.

    ModerateFDAJun 10, 2026Spectra Medical Devices

  • Eugia lidocaine HCl injection recalled for label barcode problem

    The label wrap on Eugia US LLC lidocaine HCl Injection, USP 2%, 40 mg/2 mL single-dose vials covers the barcode, making it hard to scan. The recall covers 168,300 vials in two lots distributed nationwide. No injuries have been reported.

    FDAJun 10, 2026Eugia

  • PRED MILD eye drops recalled for failed stability specifications

    AbbVie is recalling specific lots of PRED MILD (prednisolone acetate) eye drops because they failed stability testing. The affected product may not maintain its intended strength or safety over time. Two lots are involved, with an expiration date of August 2026.

    ModerateFDAJun 3, 2026AbbVie

  • Aveva nicotine patches recalled for failed impurity specifications

    AVEVA nicotine patches (14 mg) distributed by Rugby Laboratories have elevated levels of chemical impurities that exceed safety standards for shelf life. The issue was discovered during stability testing of specific lots. No injuries have been reported.

    ModerateFDAJun 3, 2026AVEVA

  • MG217 Multi-Symptom Cream recalled for Staphylococcus aureus contamination

    Wisconsin Pharmacal Company's MG217 Multi-Symptom Treatment Cream (colloidal oatmeal 2%, 6 oz) has been found to contain Staphylococcus aureus bacteria. The contamination was confirmed in lot #1024088 (expiration 11/30/2026). About 690 tubes were distributed nationwide and to the Bahamas.

    SeriousFDAMay 27, 2026Wisconsin Pharmacal

  • Safecor Health Nephronex vitamin supplement recalled for foreign particles

    Safecor Health's Nephronex vitamin B-complex, vitamin C, and folic acid oral liquid supplement was found to contain black particles in the liquid. The affected product is supplied in 5 mL oral syringes. The contamination was identified in three specific lots distributed in Ohio.

    ModerateFDAMay 27, 2026Safecor Health

  • IntegraDose fentanyl citrate injection recalled for subpotency

    IntegraDose Compounding Services LLC has recalled fentanyl citrate sterile injection (2,250 mcg/50 mL) because the drug may contain less active ingredient than labeled. This lot was distributed nationwide to healthcare facilities.

    ModerateFDAMay 27, 2026IntegraDose

  • Cimzia prefilled syringes recalled for lack of sterility assurance

    UCB Biosciences is recalling specific lots of Cimzia (certolizumab pegol) 200 mg prefilled syringes because the manufacturer cannot confirm the product remained sterile during production. This is a precautionary recall; no infections or injuries have been reported so far.

    ModerateFDAMay 27, 2026UCB Biosciences

  • Zydus erythromycin tablets recalled for nitrosamine impurity above limit

    Zydus Pharmaceuticals is recalling erythromycin tablets (250 mg) due to the presence of N-Nitroso-Desmethyl-Erythromycin, a nitrosamine impurity, at levels above the FDA's acceptable intake limit. The affected bottles were distributed nationwide. This impurity can potentially increase cancer risk with long-term exposure.

    ModerateFDAMay 27, 2026Zydus2 products

  • ANI Pharmaceuticals estradiol gel recalled for defective packets

    ANI Pharmaceuticals is recalling estradiol gel (0.1%, 0.25 mg packets) because some packets in affected cartons were found to be empty or only partially filled. This could mean patients receive less medication than prescribed. The recall affects carton lot M251109, which expires in November 2027.

    ModerateFDAMay 27, 2026ANI Pharmaceuticals

  • Gas-X softgels recalled for incomplete ingredient labeling

    Gas-X Simethicone 125 mg softgels distributed by Haleon are being recalled because the carton labeling does not list all inactive ingredients. This affects three specific lot codes (KB5Y, MP4B, and SS4F) distributed nationwide.

    ModerateFDAMay 27, 2026Haleon

Explore other recall topics